Committee (IACUC) in the local interpretation and application of the law. is responsible for establishing guidelines and policies regulating animal use. reviewing protocols with surgical components. anesthesia/analgesia selection, and post-operative care and analgesia.
AYou will receive treatment with OPDIVO in a hospital or clinic, under the supervision of an experienced doctor. OPDIVO will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 60 minutes, every 2 weeks.
The patient was switched to a second-line VRD combination chemotherapy. The VRD schedule was adapted with a weekly dexamethasone (20 mg) and bortezomib (VelcadeÂ® intravenous infusion, 1Â·3 mg/m2) administration (days 1, 8) and a reduced lenadomide (RevlimidÂ®) dose (15 mg from day 1 to 14).